Opportunities and Risks
QIAGEN’s business, like that of any other company, involves significant opportunities and risks. Effective management is paramount in delivering sustainable value creation, and the central task of the leadership team. To sustain QIAGEN’s growth, effective execution is crucial in the development and commercialization of new products; structure and implementation of acquisitions and strategic partnerships; and response to the wide variety of developments in markets where QIAGEN operates around the world. Managing opportunities and risks is an integral part of the corporate governance system in place throughout QIAGEN, not the task of one particular organizational unit. Management systems are in place to aggregate all risks and opportunities for review at the Managing Board and Supervisory Board levels of QIAGEN N.V., and these are reviewed on a routine basis. Based on our assessment at the end of 2019, we consider the opportunities and risks manageable and the survival of QIAGEN not in danger, the same position taken at year-end 2018. This assessment is supported by our strong balance sheet and the current business outlook, and further supported by the positive historical response to our external financing needs. As a result, QIAGEN has not sought an official rating by any of the leading rating agencies. We are confident in the future earnings strength of QIAGEN and have access to the resources to pursue value-creating business opportunities.